Cat. No. 2768
Chemical Name: N-(5-Chloro-2-methoxyphenyl)-N'-(2-methyl-4-quinolinyl)urea
Biological ActivityInsulin-like growth factor receptor (IGF1R) inhibitor. Suppresses IGF-stimulated IGF-IR autophosphorylation with an IC50 value of 12 μM. Inhibits growth of MCF-7 breast cancer cells in vitro and in vivo.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Anderson et al (2006) Parallel synthesis of diarylureas and their evaluation as inhibitors of insulin-like growth factor receptor. J.Comb.Chem. 8 784. PMID: 16961415.
Gable et al (2006) Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol.Cancer 5 1079.
Sivakumar et al (2009) Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition. 34 329. PMID: 19148466.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: PQ 401, supplier, IGF-IR, inhibitors, Receptors, Insulin-like, Receptor, Tyrosine, Kinases, RTKs, PQ401
Find multiple products by catalog number
New Products in this Area
Multi-RTK inhibitor; inhibits angiogenesisGNF 5837
Potent Trk inhibitor; inhibits TrkA, TrkB and TrkCHKI 357
Dual irreversible inhibitor of ErbB2 and EGFR
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.